Enanta Pharmaceuticals
ENTA
#8971
Rank
C$0.15 B
Marketcap
$7.42
Share price
-0.58%
Change (1 day)
-56.61%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - P/B ratio

P/B ratio as of February 2025 : 0.8446

According to Enanta Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 1.60857.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Enanta Pharmaceuticals - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-310.9889-4.25%
2023-12-311.03-67.89%
2022-12-313.22-19.38%
2021-12-313.99113.3%
2020-12-311.87-26.3%
2019-12-312.54-21.32%
2018-12-313.23-8.74%
2017-12-313.5348.58%
2016-12-312.381.29%
2015-12-312.35-51.94%
2014-12-314.895.25%
2013-12-314.64
2012-12-31N/A
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
53.9 6,276.21%๐Ÿ‡บ๐Ÿ‡ธ USA
5.23 518.82%๐Ÿ‡บ๐Ÿ‡ธ USA
7.60 799.34%๐Ÿ‡บ๐Ÿ‡ธ USA
5.63 566.10%๐Ÿ‡บ๐Ÿ‡ธ USA
6.95 722.68%๐Ÿ‡บ๐Ÿ‡ธ USA
4.81 470.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland